drugset / Trial / NCT04914221

The Safety and PK Characteristics of the Co-administration of JLP-2002 and Comparator in Healthy Volunteers

NCT04914221 ↗

Phase 1 Completed 42 enrolled Jeil Pharmaceutical Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

A randomized, open-label, single-dose, replicate crossover study to compare the pharmacokinetics and safety in healthy adult volunteers following oral administration of JLP-2002

Timeline

Start
2021-03-13
Primary completion
2021-05-26
Completion
2021-05-26

Drugs

EvaluationDrugModalityDoseRoute
Subject JLP-2002 Unknown — Oral

Indications